Literature DB >> 8329280

Diagnosis and treatment of human hydatidosis.

H Wen1, R R New, P S Craig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8329280      PMCID： PMC1381596          DOI： 10.1111/j.1365-2125.1993.tb04182.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  59 in total

1.  Immune status during albendazole therapy for hydatidosis.

Authors:  R M Matossian; G N Awar; H Radwan; P S Craig; G A Meshefedjian
Journal:  Ann Trop Med Parasitol       Date:  1992-02

2.  Echinococcus multilocularis: in vivo results of therapy with albendazole and praziquantel.

Authors:  D H Taylor; D L Morris; K S Richards; D Reffin
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

3.  Serum and cyst concentrations of mebendazole and flubendazole in hydatid disease.

Authors:  D L Morris; S E Gould
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-17

4.  Scanning in hydatid disease.

Authors:  M Alltree
Journal:  Clin Radiol       Date:  1979-11       Impact factor: 2.350

5.  Factors influencing the response to chemotherapy in human cystic echinococcosis.

Authors:  T Todorov; G Mechkov; K Vutova; P Georgiev; I Lazarova; Z Tonchev; G Nedelkov
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

6.  Parasitologic findings in percutaneous drainage of human hydatid liver cysts.

Authors:  C Filice; G Di Perri; M Strosselli; F Pirola; E Brunetti; S Dughetti; E Concia
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

7.  Determination of minimum effective concentration of praziquantel in in vitro cultures of protoscoleces of Echinococcus granulosus.

Authors:  D L Morris; D Taylor; D Daniels; K S Richards
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

8.  Towards global control of cystic and alveolar hydatid diseases.

Authors:  M A Gemmell; J R Lawson; M G Roberts
Journal:  Parasitol Today       Date:  1987-05

9.  Mode of action of benzimidazoles.

Authors:  E Lacey
Journal:  Parasitol Today       Date:  1990-04

10.  Effect of plasma mebendazole concentrations in the treatment of human echinococcosis.

Authors:  W Woodtli; J Bircher; F Witassek; J Eckert; B Wüthrich; R W Ammann
Journal:  Am J Trop Med Hyg       Date:  1985-07       Impact factor: 2.345
View more
  19 in total

1.  Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates.

Authors:  R Riganò; S Ioppolo; E Ortona; P Margutti; E Profumo; M D Ali; B Di Vico; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

2.  Assessment of Echinococcus granulosus somatic protoscolex antigens for serological follow-up of young patients surgically treated for cystic echinococcosis.

Authors:  Nadia Ben Nouir; Sandra Nuñez; Christian Gianinazzi; Mohamed Gorcii; Norbert Müller; Abdellatif Nouri; Hamouda Babba; Bruno Gottstein
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

3.  Sonographic management of complicated cystic echinococcosis.

Authors:  M Caremani; L Lapini; D Tacconi; P Giorni; S Corradini; R Giaccherini
Journal:  J Ultrasound       Date:  2007-10-22

4.  Serum cytokine detection in the clinical follow up of patients with cystic echinococcosis.

Authors:  R Riganò; E Profumo; S Ioppolo; S Notargiacomo; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

5.  Galα1-4Galβ1-3GalNAc is the dominant epitope of Em2 antigen, the mucin-type glycoprotein from Echinococcus multilocularis.

Authors:  Kimiaki Yamano; Akihiko Koizumi; Tadahiro Takeda; Fumiyuki Kiuchi; Noriyasu Hada
Journal:  Parasitol Res       Date:  2012-03-31       Impact factor: 2.289

6.  Immunodiagnosis of Echinococcus infections: confirmatory testing and species differentiation by a new commercial Western Blot.

Authors:  M Liance; V Janin; S Bresson-Hadni; D A Vuitton; R Houin; R Piarroux
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Cloning and immunological characterisation of Echinococcus granulosus ferritin.

Authors:  K Ersfeld; P S Craig
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

8.  Enhancement of the dissolution of albendazole from pellets using MTR technique.

Authors:  Mohamed A Ibrahim; Fars K Al-Anazi
Journal:  Saudi Pharm J       Date:  2012-03-19       Impact factor: 4.330

9.  Japanese monkey (Macaca fuscata) with alveolar echinococcosis after treatment with albendazole for 10 years: serodiagnosis and determination of albendazole metabolites.

Authors:  Kimiaki Yamano; Akio Kanetoshi; Akiko Goto; Miori Kishimoto; Nobuyuki Kobayashi; Satoshi Fujimoto; Kazutaka Yamada
Journal:  Parasitol Res       Date:  2009-09-16       Impact factor: 2.289

10.  In vitro scolicidal effect of Satureja khuzistanica (Jamzad) essential oil.

Authors:  Mohammad Moazeni; Mohammad Jamal Saharkhiz; Ali Akbar Hoseini; Amir Mootabi Alavi
Journal:  Asian Pac J Trop Biomed       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.